Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors (Q28294390)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors	scientific article

Statements

scholarly article

0 references

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors (English)

0 references

author name string

J I Weitz

1

0 references

M Hudoba

2

0 references

D Massel

3

0 references

J Maraganore

4

0 references

J Hirsh

5

0 references

language of work or name

0 references

publication date

August 1990

0 references

Journal of Clinical Investigation

0 references

86

0 references

2

0 references

385-91

0 references

Labelling of plasma proteins with radioactive iodine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Mechanism of the anticoagulant action of heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Measurement of fibrinopeptide A in human blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

A two-step fibrinogen--fibrin transition in blood coagulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

29 September 2017

The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

2 June 2018

Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

2 June 2018

Human alpha-thrombin binding to nonpolymerized fibrin-Sepharose: evidence for an anionic binding region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

2 June 2018

Kinetics of the inhibition of thrombin by hirudin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

2 June 2018

Inhibited thrombins. Interactions with fibrinogen and fibrin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

2 June 2018

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

2 June 2018

Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

2 June 2018

Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296739

2 June 2018

NOTE ON THE ADSORPTION OF THROMBIN ON FIBRIN

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective immobilization of alpha-thrombin by surface-bound fibrin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin kinetics in venous thrombosis and pulmonary embolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D-PHE-PRO-ARGCH2Cl-A selective affinity label for thrombin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Equilibrium binding of thrombin to platelets

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticoagulant activity of synthetic hirudin peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of the binding site on fibrin for the secondary binding site of thrombin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The binding of thrombin by fibrin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2384594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28294390&oldid=1993713216"